Phase I Study To Evaluate The Toxicity And Feasibility Of Intratumoral Injection Of Alpha-Gal (Beta-galactosidase ) Glycosphingolipids In Patients With Advanced Melanoma
Phase of Trial: Phase I
Latest Information Update: 24 Mar 2015
At a glance
- Drugs AGI 134 (Primary)
- Indications Malignant melanoma
- Focus Adverse reactions
- 18 Mar 2015 Status changed from active, no longer recruiting to completed, according to to ClinicalTrials.gov record.
- 19 Mar 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 22 May 2013 Planned number of patients changed from 24 to 12 as reported by ClinicalTrials.gov.